Futura Medical (LON:FUM) Trading Up 18.7% – Here’s Why

Futura Medical plc (LON:FUM)’s stock price was up 18.7% during mid-day trading on Wednesday . The stock traded as high as GBX 0.75 and last traded at GBX 0.71. Approximately 339,071 shares were traded during trading, a decline of 95% from the average daily volume of 6,199,237 shares. The stock had previously closed at GBX 0.60.

Futura Medical Stock Up 5.4%

The business has a 50 day moving average of GBX 1 and a 200 day moving average of GBX 1.17. The company has a market capitalization of £4.17 million, a P/E ratio of -0.26 and a beta of 0.01.

Futura Medical (LON:FUM) last announced its quarterly earnings results on Wednesday, April 29th. The company reported GBX (2.78) EPS for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. The firm had revenue of GBX 170 million for the quarter. On average, research analysts anticipate that Futura Medical plc will post 2.8486672 EPS for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.